← Back to Clinical Trials
Recruiting NCT06307691

NCT06307691 Clinical and Radiographic Evaluation of Immediate Implant Placement Using Osseodensification Versus Traditional Drilling Protocol

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06307691
Status Recruiting
Phase
Sponsor Cairo University
Condition Implant Complication
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2024-03-06
Primary Completion 2025-12-20

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Conventional drillingOsseodensification drilling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2024-03-06 with a primary completion date of 2025-12-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

For the purpose of the study, patients will be divided into two groups, i.e., Group A and Group B. In Group (A), 14 immediate implants will be placed using traditional drilling technique, while in Group (B), 14 immediate implants will be placed using OD drilling technique Osseodensification is a system for implant osteotomy preparation, it compresses the cancellous bone around the revolving drills. It largely improves low bone volume by physically increasing the interlocking between the bone and the implant surface. The Densah burs enhances bone density while generating the least amount of heat. Traditional oversized drilling is the regular manufacturer recommended technique of drilling. It functions by cutting the bone during osteotomy preparation by sharp fluted drills. The undersizing of the preparation allows the implant to partially compact the bone during insertion. The objective of the current study is to compare between osseodensification drilling protocol versus traditional undersized drilling protocol in immediate implant placement in anterior maxillary region in terms of implant stability.

Eligibility Criteria

Inclusion Criteria: * Patients in need of extraction of a single, unrestorable tooth in the esthetic zone including maxillary anteriors and premolars * Age range between 20-60 years old * An intact buccal plate of bone after extraction * Medically free patients (Brightman. 1994) * Cooperative patients willing to follow up for the duration of the study. Exclusion Criteria: * Acute infection in the implant site * Patients incapable of maintaining oral hygiene * Pregnant and nursing female patients * Smokers (more than 5 cigarettes per day) * A habit of bruxism * Periodontal disease * Subjects who have a systemic disease which affects bone healing as diabetes * Use of bone metabolism medicines; (Bisphosphonates) .

Contact & Investigator

Central Contact

Omar M Ibrahim, Master

✉ omar_ibrahim@dentistry.cu.edu.eg

📞 010000953710

Principal Investigator

Omar M Ibrahim, Master

PRINCIPAL INVESTIGATOR

Cairo University

Frequently Asked Questions

Who can join the NCT06307691 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Implant Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06307691 currently recruiting?

Yes, NCT06307691 is actively recruiting participants. Contact the research team at omar_ibrahim@dentistry.cu.edu.eg for enrollment information.

Where is the NCT06307691 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06307691 clinical trial?

NCT06307691 is sponsored by Cairo University. The principal investigator is Omar M Ibrahim, Master at Cairo University. The trial plans to enroll 26 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology